Answers are grounded in this paper and cite their sources.
Background and Objective The misdiagnosis of epilepsy is a problem that 25-30% of patients all around the world have to deal with, which results in the use of incorrect treatments, imposing restrictions on life unnecessarily, and making other underlying conditions' care delayed. The limitations of the classic techniques are the subjectivity of EEG interpretation, 20-30% inter-observer variability, and ictal phenomena being only partially captured. This review evaluates thoroughly the potential of using artificial intelligence (AI) for detection of seizures and epilepsy management individually in order to tackle the diagnostic problems. Methodology: A detailed review of the literature has been done to consider the AI interventions in different areas, including deep learning-based EEG signal processing, computer vision for semiological characterization, new wearable biosensors, and machine learning methods to improve personalized treatment. The assessments of effectiveness focused on diagnostic accuracy, clinical validity, and the practicality of real-world implementation Results: AI offers a practical solution for addressing misdiagnosis and advancing precision medicine in epilepsy treatment. There is enough evidence to support the prompt use of validated AI technology in clinical settings. This can enhance diagnosis accuracy, help tailor treatments for individual patients, and ensure broad access to quality epilepsy care. The presence of enforceable regulations, demonstrated effectiveness in clinical trials, and the pressing need to improve the lives of those impacted by epilepsy all support a teamwork-based approach to incorporating AI into regular clinical practice for epilepsy care. Conclusions: AI marks a paradigm shift from misdiagnosis to precision medicine to maximize care for patients with epilepsy. There is evidence to support the immediate utilization of innovative AI technology developed to improve diagnostic accuracy, specify and optimize treatment for individuals with epilepsy, and disseminate high-quality expert care to all patients, regardless of geography. The convergence of regulatory approval, proof of utility, and synthesized clinical need compel us to adopt a systematic integration of AI into daily practice for epilepsy.
No takes yet. Share an insight, caveat, or question.
A et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: